New insights into the immunopathogenesis of systemic lupus erythematosus - PubMed (original) (raw)

Review

. 2016 Nov 22;12(12):716-730.

doi: 10.1038/nrrheum.2016.186.

Affiliations

Review

New insights into the immunopathogenesis of systemic lupus erythematosus

George C Tsokos et al. Nat Rev Rheumatol. 2016.

Abstract

The aetiology of systemic lupus erythematosus (SLE) is multifactorial, and includes contributions from the environment, stochastic factors, and genetic susceptibility. Great gains have been made in understanding SLE through the use of genetic variant identification, mouse models, gene expression studies, and epigenetic analyses. Collectively, these studies support the concept that defective clearance of immune complexes and biological waste (such as apoptotic cells), neutrophil extracellular traps, nucleic acid sensing, lymphocyte signalling, and interferon production pathways are all central to loss of tolerance and tissue damage. Increased understanding of the pathogenesis of SLE is driving a renewed interest in targeted therapy, and researchers are now on the verge of developing targeted immunotherapy directed at treating either specific organ system involvement or specific subsets of patients with SLE. Accordingly, this Review places these insights within the context of our current understanding of the pathogenesis of SLE and highlights pathways that are ripe for therapeutic targeting.

PubMed Disclaimer

References

    1. Immunity. 2015 Jun 16;42(6):1159-70 - PubMed
    1. FEBS Lett. 2011 Dec 1;585(23):3603-10 - PubMed
    1. Am J Med Genet A. 2015 Feb;167A(2):296-312 - PubMed
    1. Nature. 2013 Dec 19;504(7480):446-50 - PubMed
    1. J Rheumatol. 2016 Mar;43(3):541-51 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources